EVEROLIMUS tablet United States - English - NLM (National Library of Medicine)

everolimus tablet

par pharmaceutical, inc. - everolimus (unii: 9hw64q8g6g) (everolimus - unii:9hw64q8g6g) - everolimus tablets are indicated for the prophylaxis of organ rejection in adult patients at low-moderate immunologic risk receiving a kidney transplant [see clinical studies (14.1) ] everolimus is to be administered in combination with basiliximab induction and concurrently with reduced doses of cyclosporine and with corticosteroids. tdm of everolimus and cyclosporine is recommended for all patients receiving these products. [see dosage and administration (2.2, 2.3) ] everolimus is indicated for the prophylaxis of allograft rejection in adult patients receiving a liver transplant. everolimus is to be administered no earlier than 30 days post-transplant concurrently in combination with reduced doses of tacrolimus and with corticosteroids [see warnings and precautions (5.5) and clinical studies (14.2) ]. therapeutic drug monitoring (tdm) of everolimus and tacrolimus is recommended for all patients receiving these products. [see dosage and administration (2.3, 2.5) ] the safety and efficacy of everolimus has no

REDDY-EVEROLIMUS TABLET Canada - English - Health Canada

reddy-everolimus tablet

dr reddy's laboratories ltd - everolimus - tablet - 2.5mg - everolimus 2.5mg

REDDY-EVEROLIMUS TABLET Canada - English - Health Canada

reddy-everolimus tablet

dr reddy's laboratories ltd - everolimus - tablet - 5mg - everolimus 5mg

REDDY-EVEROLIMUS TABLET Canada - English - Health Canada

reddy-everolimus tablet

dr reddy's laboratories ltd - everolimus - tablet - 7.5mg - everolimus 7.5mg

REDDY-EVEROLIMUS TABLET Canada - English - Health Canada

reddy-everolimus tablet

dr reddy's laboratories ltd - everolimus - tablet - 10mg - everolimus 10mg

PMS-EVEROLIMUS TABLET Canada - English - Health Canada

pms-everolimus tablet

pharmascience inc - everolimus - tablet - 2.5mg - everolimus 2.5mg - antineoplastic agents

PMS-EVEROLIMUS TABLET Canada - English - Health Canada

pms-everolimus tablet

pharmascience inc - everolimus - tablet - 5mg - everolimus 5mg - antineoplastic agents

PMS-EVEROLIMUS TABLET Canada - English - Health Canada

pms-everolimus tablet

pharmascience inc - everolimus - tablet - 10mg - everolimus 10mg - antineoplastic agents

NAT-EVEROLIMUS TABLET Canada - English - Health Canada

nat-everolimus tablet

natco pharma (canada) inc - everolimus - tablet - 2.5mg - everolimus 2.5mg

NAT-EVEROLIMUS TABLET Canada - English - Health Canada

nat-everolimus tablet

natco pharma (canada) inc - everolimus - tablet - 5mg - everolimus 5mg